Best Chemotherapy doctors in Germany: TOP 17 doctors

Dr. Axel Stang is a professor, Head Physician of Asklepios Barmbek Clinic, with a specialization in internal medicine, oncology, and hematology. He conducts antibody and molecular therapies to reduce tumor size, and is a member of multiple organizations and societies. Dr. Stang has published articles on the effectiveness of radiofrequency ablation in treating of metastatic colon cancer, and was a member of a research group that studied the effects of liver embolization. Patients can submit a request on the Bookimed website to get a consultation with the professor.

Prof. Ralf Buhl is world famous neurosurgeon with over 20 years of experience. Doctor Buhl heads the Neurosurgery Department at Solingen Klinikum. His reputation reaches China and the US where he provides neurosurgical lectures.

Specialty

Dr. Buhl specializes in non-invasive methods treatment of disc herniation, brain and spinal cord tumors. The doctor provides treatment of peripheral nervous system disorders and performs computer-assisted navigation microsurgeries.

Dr. Ralf Buhl has provided over 4,000 successful neurosurgeries. Among his patients are famous politicians, businessmen, musicians, actors. In 2015, a Hollywood star George Clooney had severe back pain and was treated by Professor Buhl.

Scientific activity

Dr. Buhl conducts scientific work and researches in intracranial cavernomas treatment, surgical treatment for brain metastases and other neurosurgery areas.

Рrofessor Buhl has cofound the Fund devoted to the study of brain tumors.

• Utilizes targeted drug therapy and combination chemotherapy techniques.
• Trained in Germany, with additional oncology specialization in the USA.
• Member of the German Society of Gastroenterology.
• Certified in internal medicine and gastroenterology.
• Authored over 130 publications in oncology and gastroenterology.

• Specializes in administering intravenous and oral chemotherapy.
• Trained in Germany, with international exposure in the USA and UK.
• Ranked as a top oncologist by Focus magazine in Germany.
• Certified by the German Board of Oncology and Hematology.
• Member of the German Cancer Society and European Oncology Society.

Professor Jorg Groticke is the Chief Physician of the Oncology and Hematology Center at Bremen Mitte Hospital, specializing in the treatment of hematological malignancies and gastrointestinal tract tumors. He is a member of multiple medical organizations, and offers remote consultations for second opinions.

• Utilizes targeted therapy and immunotherapy in chemotherapy treatments.
• Trained in Germany, USA, and the UK.
• Certified by the American Board of Hematology.
• Member of the European Hematology Association.
• Specializes in chemotherapy for non-Hodgkin lymphoma.

Doctor, Oncologist

Head of Cancer Center

Urologist, oncologist, specialist in robotic surgery

Membership in societies:

German Society of Oncology and Haemato-oncology GDHO
German Association of Physicians

American Association for Cancer Research

Expert in scientific journals 

Close collaboration with leading haematologists 

Involved in molecular biology research on the treatment of haemato-oncological diseases

Specialization:

Comprehensive treatment of tumour diseases, in particular chemotherapy, immunotherapy, immunotherapy, targeted therapy, radiation therapy molecular diagnostics.

Work experience:

2006: Graduation from the Faculty of Medicine of the University of Köln

2011: Specialization ‘Haematologist, Oncologist and Immunologist’

2011: Deputy Chief Physician of the Pulmonology Clinic Köln, Haematologist, Oncologist and Immunologist. Cologne, Haemato-oncologist and senior palliative care physician

2016: Qualification as a specialist in genetics

2021: Chief Physician of the Clinic for Haematology, Oncology and Palliative Care at the certified interdisciplinary cancer centre BKZ Solingen.

Dr. Fox is also actively involved in molecular biology research to develop and implement innovative treatments for haemato-oncological diseases. Her scientific work in this area has contributed to significant advances in understanding the molecular mechanisms of cancer and the development of effective therapies.

Dr. Fox specializes in the comprehensive treatment of tumour diseases, including chemotherapy, immunotherapy, targeted therapies, radiation therapy and molecular diagnostics.

Throughout her career, Dr. Fox has proven herself to be an outstanding specialist, constantly innovating treatment methods and approaches. Her patients receive the most effective and state-of-the-art treatments, which has earned her recognition and respect amongst colleagues and patients alike.

She completed her training at the Charité in Berlin and has been a specialist in radiotherapy for 20 years. She worked as a senior physician in all departments of the Charité in Berlin, and from 2007 to 2015 she was a senior physician and deputy director of the Charité clinic in Berlin. In 2015, she was appointed head of the department of radiotherapy at the University Hospital of Cologne and very successfully headed the clinic there until 2022. Since the end of 2022, she has been heading the private radiotherapy clinic "RadioOnkologie Vosspalais". Clinical areas include radioimmunotherapy, high-precision therapy, multimodal therapy of gynecological tumors and prostate carcinoma.

Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Several randomized clinical trials have been conducted under her leadership.

Professor Dr. Marnitz is an honorary member of the Russian Society of Gynecological Oncology, a member of the professional societies DEGRO, ESTRO, ASTRO. In 2024, Professor Dr. Marnitz will be the president of the congress of the annual conference of the German Society of Radiation Oncology.

Prof. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach

He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.

She received her medical education in Russia. After completing her residency in Berlin, Dr. Steingraeber worked as a specialist and senior physician at the Charité, the Neukölln Hospital in Berlin and in the practice of radiooncology. Dr. Steingraeber speaks fluent Russian. Her clinical specialization includes bronchial carcinoma and breast carcinoma.

Membership/Committee Service:

DEGRO, ARO, DKG, AGSMO

Member of interdisciplinary committees for the development of guidelines:

Esophageal carcinoma

Anal carcinoma

Oropharyngeal/hypopharyngeal carcinoma

Supportive therapy in oncology

Dr. Séverine Iborra is the Chief Physician of the Department of Gynecology and Obstetrics at Städtisches Klinikum Solingen. Her responsibilities include obstetrics, the delivery room, the neonatal unit, and gynecology. The department also includes the Senology/Breast Clinic at the Bergisches Breast Center Solingen, led by Dr. Manuela Seifert.

Dr. Séverine Iborra is originally from France. She began her medical studies at the University of Lyon and later transferred to Albert-Ludwigs University in Freiburg, where she received her medical license in 2007. She earned her doctorate in 2008 for experimental research in molecular oncology. From August 2008 to November 2013, Dr. Iborra worked as a resident at the University Women’s Clinic in Freiburg. After passing her specialist exams in gynecology and obstetrics, she continued her career as a specialist at the same clinic. In November 2015, she moved to RWTH University Hospital Aachen as a senior physician.

At the Clinic for Gynecology and Obstetrics, under the leadership of Prof. Dr. E. Stickeler, Dr. Iborra led the obstetrics department from 2017 to 2019. Since December 2017, she was responsible for organizing education in the department, and in October 2019, she became the Managing Senior Physician and Personnel Senior Physician of the clinic, a position she held until she moved to Solingen.

In addition to her scientific work, with numerous publications and presentations at major gynecological conferences, Dr. Iborra deepened her medical specialties. She obtained certifications in oncological diagnostics and therapy from the Gynecological Oncology Working Group, as well as additional qualifications in Cervical Pathology and Colposcopy (AGCPC), Urogynecology and Pelvic Reconstructive Surgery (AGUP), and the Professional Association of Gynecologists (BVF).

In 2019, Dr. Iborra successfully completed further specialization in “Gynecological Oncology” and “Special Obstetrics and Perinatal Medicine.” She is an active member of leading German medical societies in her field, including the German Society for Gynecology and Obstetrics, the Cervical Pathology and Colposcopy Working Group, and the German Society for Prenatal and Birth Medicine.

Treatments Offered in Our Gynecology Department

• Hysteroscopy and Dilation and Curettage (D&C) for diagnostic and therapeutic purposes.
• Removal of abnormal or symptomatic ovarian findings, such as cysts, while preserving the remaining ovary.
• Oophorectomy (removal of ovaries) in cases of abnormalities or preventively when indicated.
• Myomectomy (removal of uterine fibroids) while preserving the uterus.
• Conservative treatment of fibroids: either medication or embolization performed by radiology specialists.
• Hysterectomy with or without removal of the cervix.
• Diagnosis and clarification of unclear findings in the cervix, vagina, and vulva.
• Dysplasia treatment.
• Endometriosis management.
• Cancer treatment for vulvar, vaginal, cervical, uterine, and ovarian cancers.
• Treatment for incontinence and/or pelvic organ prolapse.

Whenever possible, we offer all procedures as minimally invasive treatments using laparoscopy or the Da Vinci robotic system.

Prof. Dr. med. Ulrich Graven

Head of the Clinic of Hematology, Oncology and Gastroenterology

Head of a certified oncology center

Head of Clinical Research Department

Specialization:

Hematology, including stem cell transplantation

Abdominal oncology, especially colorectal and pancreatic cancer therapy

Metastasis therapy, including the use of off-label drugs

Membership in professional societies:

Professional Union of German Therapists

German Society for Internal Medicine

German Cancer Society

Abdominal Oncology Working Group

German Society of Hematology and Oncology

German Working Group on Bone Marrow and Hematopoietic Stem Cell Transplantation

German Society for Digestive and Metabolic Diseases

European Society for Medical Oncology

American Society of Clinical Oncology

American Association for Cancer Research

Activities in professional communities:

German Cancer Society:

Since 2013, speaker of the commission for certification of oncology centers

Since November 2007, member of the board

Since September 2022, Speaker of the Section of National Societies on Cancer Control

Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.

Chairman of the Oncology Society of North Rhine-Westphalia.

Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.

Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.

Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.

Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.

Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.

Member of the committee for the development of clinical guidelines for colorectal cancer.

Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.

Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.